258 related articles for article (PubMed ID: 17875779)
1. Short-term modulation of cell proliferation and apoptosis and preventive/therapeutic efficacy of various agents in a mammary cancer model.
Christov K; Grubbs CJ; Shilkaitis A; Juliana MM; Lubet RA
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5488-96. PubMed ID: 17875779
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers.
Grubbs CJ; Lubet RA; Atigadda VR; Christov K; Deshpande AM; Tirmal V; Xia G; Bland KI; Eto I; Brouillette WJ; Muccio DD
Carcinogenesis; 2006 Jun; 27(6):1232-9. PubMed ID: 16344269
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Targretin on methylnitrosourea-induced mammary cancers: prevention and therapy dose-response curves and effects on proliferation and apoptosis.
Lubet RA; Christov K; Nunez NP; Hursting SD; Steele VE; Juliana MM; Eto I; Grubbs CJ
Carcinogenesis; 2005 Feb; 26(2):441-8. PubMed ID: 15591091
[TBL] [Abstract][Full Text] [Related]
4. Lack of efficacy of the statins atorvastatin and lovastatin in rodent mammary carcinogenesis.
Lubet RA; Boring D; Steele VE; Ruppert JM; Juliana MM; Grubbs CJ
Cancer Prev Res (Phila); 2009 Feb; 2(2):161-7. PubMed ID: 19196723
[TBL] [Abstract][Full Text] [Related]
5. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol.
Grubbs CJ; Steele VE; Casebolt T; Juliana MM; Eto I; Whitaker LM; Dragnev KH; Kelloff GJ; Lubet RL
Anticancer Res; 1995; 15(3):709-16. PubMed ID: 7645947
[TBL] [Abstract][Full Text] [Related]
7. Use of Biomarker Modulation in Normal Mammary Epithelium as a Correlate for Efficacy of Chemopreventive Agents Against Chemically Induced Cancers.
Lubet RA; Heckman-Stoddard BM; Fox JT; Moeinpour F; Juliana MM; Shoemaker RH; Grubbs CJ
Cancer Prev Res (Phila); 2020 Mar; 13(3):283-290. PubMed ID: 31871222
[TBL] [Abstract][Full Text] [Related]
8. Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma.
Bischoff ED; Gottardis MM; Moon TE; Heyman RA; Lamph WW
Cancer Res; 1998 Feb; 58(3):479-84. PubMed ID: 9458093
[TBL] [Abstract][Full Text] [Related]
9. Methylselenocysteine modulates proliferation and apoptosis biomarkers in premalignant lesions of the rat mammary gland.
Ip C; Dong Y
Anticancer Res; 2001; 21(2A):863-7. PubMed ID: 11396176
[TBL] [Abstract][Full Text] [Related]
10. Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland.
Ip C; Thompson HJ; Ganther HE
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):49-54. PubMed ID: 10667463
[TBL] [Abstract][Full Text] [Related]
11. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861
[TBL] [Abstract][Full Text] [Related]
12. Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes.
Lubet RA; Szabo E; Christov K; Bode AM; Ericson ME; Steele VE; Juliana MM; Grubbs CJ
Mol Cancer Ther; 2008 Apr; 7(4):972-9. PubMed ID: 18375820
[TBL] [Abstract][Full Text] [Related]
13. Dietary effects of conjugated docosahexaenoic acid on N-methyl-N-nitrosourea-induced mammary carcinogenesis in female Sprague-Dawley rats.
Danbara N; Uehara N; Shikata N; Takada H; Hada T; Tsubura A
Oncol Rep; 2004 Nov; 12(5):1079-85. PubMed ID: 15492796
[TBL] [Abstract][Full Text] [Related]
14. Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model.
Lubet RA; Steele VE; DeCoster R; Bowden C; You M; Juliana MM; Eto I; Kelloff GJ; Grubbs CJ
Carcinogenesis; 1998 Aug; 19(8):1345-51. PubMed ID: 9744527
[TBL] [Abstract][Full Text] [Related]
15. Glycine soya diet synergistically enhances the suppressive effect of tamoxifen and inhibits tamoxifen-promoted hepatocarcinogenesis in 7,12-dimethylbenz[α]anthracene-induced rat mammary tumor model.
Mishra R; Bhadauria S; Murthy PK; Murthy PS
Food Chem Toxicol; 2011 Feb; 49(2):434-40. PubMed ID: 21092749
[TBL] [Abstract][Full Text] [Related]
16. Effects of tetramethoxystilbene on hormone-resistant breast cancer cells: biological and biochemical mechanisms of action.
Park H; Aiyar SE; Fan P; Wang J; Yue W; Okouneva T; Cox C; Jordan MA; Demers L; Cho H; Kim S; Song RX; Santen RJ
Cancer Res; 2007 Jun; 67(12):5717-26. PubMed ID: 17575138
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
Ting AY; Kimler BF; Fabian CJ; Petroff BK
Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
[TBL] [Abstract][Full Text] [Related]
18. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
Swanson SM; Christov K
Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
[TBL] [Abstract][Full Text] [Related]
19. Lapatinib, a preventive/therapeutic agent against mammary cancer, suppresses RTK-mediated signaling through multiple signaling pathways.
Li J; Cho YY; Langfald A; Carper A; Lubet RA; Grubbs CJ; Ericson ME; Bode AM
Cancer Prev Res (Phila); 2011 Aug; 4(8):1190-7. PubMed ID: 21791570
[TBL] [Abstract][Full Text] [Related]
20. The impact of fish oil on the chemopreventive efficacy of tamoxifen against development of N-methyl-N-nitrosourea-induced rat mammary carcinogenesis.
Manni A; Xu H; Washington S; Aliaga C; Cooper T; Richie JP; Bruggeman R; Prokopczyk B; Calcagnotto A; Trushin N; Mauger D; Verderame MF; El-Bayoumy K
Cancer Prev Res (Phila); 2010 Mar; 3(3):322-30. PubMed ID: 20179301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
